WELCH & FORBES LLC – Vertex Pharmaceuticals Incorporated Transaction History
WELCH & FORBES LLC portfolio value:
$54.85M
portfolio value
WELCH & FORBES LLC quarter portfolio value change:
+2.75%
quarter
Vertex Pharmaceuticals Incorporated 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -1.44% | -2.77K shares | 686K | $289.54 | 189.45K |
| Q2 2022 | share | Decrease | -1.70% | -3.32K shares | 3.13M | $281.79 | 192.23K |
| Q1 2022 | share | Increase | +2.96% | 5.62K shares | 9.32M | $260.97 | 195.55K |
| Q4 2021 | share | Decrease | -5.99% | -12.10K shares | 5.06M | $222.45 | 189.93K |
| Q3 2021 | share | Decrease | -2.10% | -4.33K shares | -4.96M | $181.39 | 202.03K |
| Q2 2021 | share | Decrease | -1.58% | -3.31K shares | -3.44M | $201.63 | 206.36K |
| Q1 2021 | share | Increase | +9.57% | 18.31K shares | -170K | $214.89 | 209.68K |
| Q4 2020 | share | Increase | +3.62% | 6.68K shares | -5.02M | $236.34 | 191.36K |
| Q3 2020 | share | Decrease | -0.97% | -1.81K shares | -3.88M | $272.12 | 184.68K |
| Q2 2020 | share | Increase | +2.27% | 4.13K shares | 10.74M | $290.31 | 186.49K |
| Q1 2020 | share | Increase | +4.29% | 7.49K shares | 5.10M | $237.95 | 182.36K |
| Q4 2019 | share | Decrease | -0.93% | -1.64K shares | 8.38M | $218.95 | 174.86K |
| Q3 2019 | share | Increase | +0.33% | 587 shares | -2.35M | $169.42 | 176.51K |
| Q2 2019 | share | Increase | +0.85% | 1.47K shares | 171K | $183.38 | 175.92K |
| Q1 2019 | share | Decrease | -0.91% | -1.6K shares | 2.91M | $183.95 | 174.45K |
| Q4 2018 | share | Decrease | -0.22% | -386 shares | -4.83M | $165.71 | 176.05K |
| Q3 2018 | share | Increase | +2.23% | 3.84K shares | 4.67M | $192.74 | 176.43K |
| Q2 2018 | share | Decrease | -2.51% | -4.45K shares | 480K | $169.96 | 172.59K |
| Q1 2018 | share | Decrease | -0.68% | -1.21K shares | 2.14M | $162.98 | 177.04K |
| Q4 2017 | share | Decrease | -1.34% | -2.42K shares | -756K | $149.86 | 178.25K |
| Q3 2017 | share | Decrease | -3.08% | -5.75K shares | 3.44M | $152.04 | 180.67K |
| Q2 2017 | share | Increase | +0.35% | 651 shares | 3.71M | $128.87 | 186.42K |
| Q1 2017 | share | Decrease | -2.17% | -4.11K shares | 6.32M | $109.35 | 185.77K |
| Q4 2016 | share | Decrease | -1.44% | -2.76K shares | -2.81M | $73.67 | 189.89K |
| Q3 2016 | share | Decrease | -2.65% | -5.24K shares | -221K | $87.21 | 192.66K |
| Q2 2016 | share | Increase | +1.92% | 3.73K shares | 1.58M | $86.02 | 197.90K |
| Q1 2016 | share | Increase | +0.29% | 564 shares | -8.92M | $79.49 | 194.16K |